686 related articles for article (PubMed ID: 16432373)
21. Leptin, adiponectin, resistin, visfatin serum levels and idiopathic recurrent pericarditis: biomarkers of disease activity? A preliminary report.
Cantarini L; Brucato A; Simonini G; Imazio M; Cumetti D; Cimaz R; Bacarelli MR; Muscari I; Vitale A; Lucherini OM; Galeazzi M; Fioravanti A
Clin Exp Rheumatol; 2013; 31(2):207-12. PubMed ID: 23137677
[TBL] [Abstract][Full Text] [Related]
22. Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitis.
Herrlinger KR; Dittmann R; Weitz G; Wehkamp J; Ludwig D; Schwab M; Stange EF; Fellermann K
Inflamm Bowel Dis; 2004 May; 10(3):229-33. PubMed ID: 15290916
[TBL] [Abstract][Full Text] [Related]
23. Is ischemia modified albumin a disease activity marker for inflammatory bowel diseases?
Kaplan M; Yuksel M; Ates I; Kilic ZM; Kilic H; Kuzu UB; Kayacetin E
J Gastroenterol Hepatol; 2016 Jun; 31(6):1120-5. PubMed ID: 26642816
[TBL] [Abstract][Full Text] [Related]
24. Low mannose-binding lectin (MBL) is associated with paediatric inflammatory bowel diseases and ileal involvement in patients with Crohn disease.
Kovacs M; Papp M; Lakatos PL; Jacobsen S; Nemes E; Polgar M; Solyom E; Bodi P; Horvath A; Molnar K; Szabo D; Cseh A; Muller KE; Dezsofi A; Arato A; Veres G
J Crohns Colitis; 2013 Mar; 7(2):134-41. PubMed ID: 22504031
[TBL] [Abstract][Full Text] [Related]
25. Serum Adipocytokine Levels as Surrogate Markers for Disease Activity of Crohn's Disease.
Kim SH; Jang SH; Kim JW; Kim BG; Lee KL; Kim YS; Han DS; Kim JS
Am J Med Sci; 2017 May; 353(5):439-444. PubMed ID: 28502329
[TBL] [Abstract][Full Text] [Related]
26. CD8
Dai SX; Gu HX; Lin QY; Huang SZ; Xing TS; Zhang QF; Wu G; Chen MH; Tan WE; Jian HJ; Zheng ZW; Zhong T; Zhang MH; Cheng XF; Huang P; Liao GJ; Sha WH
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):693-702. PubMed ID: 28502591
[TBL] [Abstract][Full Text] [Related]
27. Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin.
Chu MC; Cosper P; Orio F; Carmina E; Lobo RA
Am J Obstet Gynecol; 2006 Jan; 194(1):100-4. PubMed ID: 16389017
[TBL] [Abstract][Full Text] [Related]
28. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
Ciećko-Michalska I; Fedak D; Mach T
Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
[TBL] [Abstract][Full Text] [Related]
29. Circadian rhythm abnormalities in patients with inflammatory bowel disease - association with adipokine profile.
Sobolewska-Włodarczyk A; Włodarczyk M; Zielińska A; Siwiński P; Wiśniewska-Jarosińska M; Gąsiorowska A; Fichna J
Scand J Gastroenterol; 2020 Mar; 55(3):294-300. PubMed ID: 32180483
[No Abstract] [Full Text] [Related]
30. Is there any interaction of resistin and adiponectin levels with protein-energy wasting among patients with chronic kidney disease.
Kaynar K; Kural BV; Ulusoy S; Cansiz M; Akcan B; Misir N; Yaman S; Kaya N
Hemodial Int; 2014 Jan; 18(1):153-62. PubMed ID: 23919731
[TBL] [Abstract][Full Text] [Related]
31. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
[TBL] [Abstract][Full Text] [Related]
32. Growth differentiation factor-15 serum concentrations reflect disease severity and anemia in patients with inflammatory bowel disease.
Tonkic A; Kumric M; Akrapovic Olic I; Rusic D; Zivkovic PM; Supe Domic D; Sundov Z; Males I; Bozic J
World J Gastroenterol; 2024 Apr; 30(13):1899-1910. PubMed ID: 38659482
[TBL] [Abstract][Full Text] [Related]
33. Serum levels of C1q/TNF-related protein-3 in inflammatory bowel disease patients and its inverse association with inflammatory cytokines and insulin resistance.
Mohamadinarab M; Ahmadi R; Gholamrezayi A; Rahvar F; Naghdalipour M; Setayesh L; Moradi N; Fadaei R; Chamani E; Tavakoli T; Esteghamati A
IUBMB Life; 2020 Aug; 72(8):1698-1704. PubMed ID: 32311832
[TBL] [Abstract][Full Text] [Related]
34. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients.
Zekri AR; Bakr YM; Ezzat MM; Zakaria MS; Elbaz TM
Asian Pac J Cancer Prev; 2015; 16(16):6923-8. PubMed ID: 26514469
[TBL] [Abstract][Full Text] [Related]
35. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis.
Otero M; Lago R; Gomez R; Lago F; Dieguez C; Gómez-Reino JJ; Gualillo O
Ann Rheum Dis; 2006 Sep; 65(9):1198-201. PubMed ID: 16414972
[TBL] [Abstract][Full Text] [Related]
36. Serum leptin, resistin, visfatin and adiponectin levels in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).
Cantarini L; Obici L; Simonini G; Cimaz R; Bacarelli MR; Merlini G; Vitale A; Lucherini OM; Brizi MG; Galeazzi M; Fioravanti A
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S108-14. PubMed ID: 22935190
[TBL] [Abstract][Full Text] [Related]
37. Serum 25-hydroxyvitamin D concentration and inflammatory bowel disease characteristics in Romania.
Dumitrescu G; Mihai C; Dranga M; Prelipcean CC
World J Gastroenterol; 2014 Mar; 20(9):2392-6. PubMed ID: 24605037
[TBL] [Abstract][Full Text] [Related]
38. Hypertrophic Mesenteric Adipose Tissue May Play a Role in Atherogenesis in Inflammatory Bowel Diseases.
Theocharidou E; Balaska A; Vogiatzis K; Tellis CC; Gossios TD; Athyros VG; Tselepis AD; Karagiannis A
Inflamm Bowel Dis; 2016 Sep; 22(9):2206-12. PubMed ID: 27508511
[TBL] [Abstract][Full Text] [Related]
39. Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?
Kahraman R; Calhan T; Sahin A; Ozdil K; Caliskan Z; Bireller ES; Cakmakoglu B
Ther Clin Risk Manag; 2017; 13():1295-1301. PubMed ID: 29033577
[TBL] [Abstract][Full Text] [Related]
40. Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity.
Oikonomou KA; Kapsoritakis AN; Theodoridou C; Karangelis D; Germenis A; Stefanidis I; Potamianos SP
J Gastroenterol; 2012 May; 47(5):519-30. PubMed ID: 22200942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
